Although it is not clear whether the increased mRNA level translates into an enhanced protein level, this supports the idea that PKD1 is a potential tumor suppressor, whereas PKD3 has oncogenic functions in breast cancer. This evidence concerns the gene PRKD3 and neoplasm.